{"id":"ckd-348-f1","brandName":"CKD-348 F1","genericName":"CKD-348 F1","companyId":"chong-kun-dang-pharmaceutical","companyName":"Chong Kun Dang Pharmaceutical","phase":"phase_1","status":"active","modality":"Small molecule","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"CKD-348 is a small molecule drug developed by Chong Kun Dang Pharmaceutical. It has completed Phase 1 clinical trials evaluating its tolerability and pharmacokinetics in healthy volunteers. No FDA label is available, and further development stages are pending.","enrichmentLevel":5,"visitCount":1,"mechanism":{},"administration":{},"safety":{},"trials":[],"indications":{"approved":[],"pipeline":[],"offLabel":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":3,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:14:57.824790+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":false,"score":0}}